Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Standard Biotools (LAB) over the last 15 years, with Q3 2025 value amounting to 0.4%.

  • Standard Biotools' Return on Invested Capital fell 1500.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.93% for FY2024, which is 23300.0% down from last year.
  • Standard Biotools' Return on Invested Capital amounted to 0.4% in Q3 2025, which was down 1500.0% from 0.36% recorded in Q2 2025.
  • Over the past 5 years, Standard Biotools' Return on Invested Capital peaked at 12.3% during Q2 2022, and registered a low of 0.86% during Q1 2022.
  • For the 5-year period, Standard Biotools' Return on Invested Capital averaged around 1.0%, with its median value being 0.35% (2025).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 128000bps in 2022, then plummeted by -104400bps in 2023.
  • Quarter analysis of 5 years shows Standard Biotools' Return on Invested Capital stood at 0.51% in 2021, then soared by 677bps to 2.92% in 2022, then plummeted by -76bps to 0.7% in 2023, then crashed by -154bps to 0.38% in 2024, then fell by -5bps to 0.4% in 2025.
  • Its last three reported values are 0.4% in Q3 2025, 0.36% for Q2 2025, and 0.35% during Q1 2025.